Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03493295
Other study ID # 19704
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 25, 2018
Est. completion date March 15, 2021

Study information

Verified date October 2023
Source Bayer
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The aim of this non-interventional study (NIS) is to assess, under real-life conditions, woman's satisfaction with Levonogestrel IntraUterine System (LNG-IUS) in a young (18-30 years old (y.o.)) Spanish population taking into account their parity status. Furthermore, the study is aimed to evaluate the impact of: menstrual bleeding pattern and satisfaction with it at baseline, LNG-IUS chosen, previously used contraceptive method and reasons for change to/ choice of a LNG-IUS on overall satisfaction with LNG-IUS use.


Recruitment information / eligibility

Status Completed
Enrollment 587
Est. completion date March 15, 2021
Est. primary completion date November 30, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 30 Years
Eligibility Inclusion Criteria: - Women in childbearing age, between 18-30 years old. - Women who have chosen a LNG-IUS as contraceptive method, after been adequately counselled by the physician about all contraceptive possible options. - Women who have chosen a LNG-IUS mainly for contraceptive reasons, not due to heavy menstrual bleeding. - Women with no desire to conceive for at least within the next 12 months. - Women capable of reading and writing Exclusion Criteria: - Women whose main reason to use a LNG-IUS is not a contraceptive reason. - Women with contraindication for LNG-IUS. - Women with previous experience with a IUS. - Women who have been diagnosed with heavy menstrual bleeding. - Women with degenerative or other kind of diseases that could directly negatively impact their daily life. - Women who have undergone a hysterectomy or irreversible contraceptive method. - Women participating in a clinical trial. - Women with a mental illness and unable to make decisions and follow instructions. - Women with amenorrhea - Women with clinical history of severe dysmenorrhea - Women with concomitant medication that may lead changes in bleeding pattern (e.g. antiplatelets and/or anticoagulants)

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Levonogestrel IntraUterine System (LNG-IUS)
At the routine clinical practice. Jaydess, Mirena, Kyleena Or any other levonogestrel intrauterine system (LNG-IUS) commercialized in Spain at the start of the study, only for contraception indication.

Locations

Country Name City State
Spain Many locations Multiple Locations

Sponsors (1)

Lead Sponsor Collaborator
Bayer

Country where clinical trial is conducted

Spain, 

References & Publications (1)

Perello Capo J, Lopez Gonzalez G, Rius-Tarruella J, Calaf Alsina J. Real-world satisfaction and menstrual bleeding pattern with available LNG-IUD among Spanish young women. Eur J Contracept Reprod Health Care. 2022 Dec;27(6):461-472. doi: 10.1080/13625187.2022.2112562. Epub 2022 Sep 23. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of subjects rating 1 (very dissatisfied) to 5 (very satisfied) in the 5-point Likert scale overall satisfaction with LNG-IUS Overall satisfaction with LNG-IUS at end of observation/final visit (i.e. after approximately 12 months or at premature discontinuation). 5 point Likert scale of overall satisfaction with LNG-IUS with end labelling "very dissatisfied" / "very satisfied" At approximately 12 months(end of observation/final visit)
Secondary Percentage of women rating 1 (very dissatisfied) to 5 (very satisfied) in the 5-point Likert scale of overall satisfaction with the menstrual bleeding profile with LNG-IUS Overall satisfaction rate with LNG-IUS at end of observation/final visit. 5 point Likert scale of overall satisfaction with the menstrual bleeding pattern with LNG-IUS with end labelling "very dissatisfied" / "very satisfied". At 4-12 weeks after insertion, At approximately 12 months(end of observation/final visit)
Secondary 8 item user satisfaction questionnaire to assess the satisfaction with menstrual bleeding pattern with LNG-IUS Overall satisfaction with the menstrual bleeding profile with LNG-IUS at end of observation/final visit. At approximately 12 months(end of observation/final visit)
Secondary Spearman's correlation between overall satisfaction with LNG-IUS and overall satisfaction with menstrual bleeding pattern At approximately 12 months(end of observation/final visit)
Secondary Percentage of subjects rating 1 (very dissatisfied) to 5 (very satisfied) in the 5-point Likert scale overall satisfaction with LNG-IUS Overall satisfaction with LNG-IUS 4-12 weeks after insertion. 5 point Likert scale of overall satisfaction with LNG-IUS with end labelling "very dissatisfied" / "very satisfied" At 4-12 weeks after insertion
Secondary Overall satisfaction with the menstrual bleeding profile 4-12 weeks after insertion. At 4-12 weeks after insertion
Secondary Ease of LNG-IUS insertion will be measured by investigator on an ordinal scale of "easy", "slightly difficult", "very difficult" Ease of LNG-IUS insertion assessed by the investigator. At initial visit (Day 0_LNG-IUS insertion)
Secondary Pain at LNG-IUS insertion will be assessed by the clinician asking to the user on a ordinal scale of "none", "mild", "moderate" or "severe" Pain at LNG-IUS insertion assessed by the user. At initial visit (Day 0_LNG-IUS insertion)
Secondary Percentage of women that would recommend a LNG-IUS to peers Response in recommendation to peers item at final visit. At approximately 12 months
Secondary Reasons for change to/ choice a LNG-IUS assessed by a multiple choice item At initial visit (Day 0_LNG-IUS insertion)
Secondary Descriptive analysis of demographic data Women's profile defined by their sociodemographic and gynaecological characteristics. At initial visit (Day 0_LNG-IUS insertion)
Secondary Reasons for withdrawal Up to approximately 12 months
Secondary Percentage of withdrawal Up to approximately 12 months
See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A